Emcure Pharmaceuticals has informed that this is with reference to email dated March 10, 2026, bearing ref. no.: L/SURV/ONL/PV/APJ/2025-2026/961, seeking clarification regarding significant increase in volume of Company’s shares/ scrip in recent past. In this connection, they clarified that, the increase in the price/ volume of the shares of the Company is market driven on which the Company has no control. Further, there is no event/ information that at present needs to be disclosed in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations). The Company is aware of its disclosure obligations and has ensured timely disclosure of any events, information, etc. required to be disclosed under Regulation 30 of the SEBI Listing Regulations and will continue to do so in future as and when any such event or information occurs in the Company.
The above information is a part of company’s filings submitted to BSE.
